CLEMENS PETER A

Director at ACURA PHARMACEUTICALS, INC · on record since Jul 2, 2003
Senior VP and CFO at ACURA PHARMACEUTICALS, INC · on record since Aug 13, 2004

Insider trading activity of CLEMENS PETER A

Transactions on record: 89; since Oct 1, 2003

Open-market buys: 8; $55.7K

Open-market sells: 12; $349.3K

Companies traded: 1; last filing Nov 20, 2023

Figures computed from official regulatory filings — .

Companies where CLEMENS PETER A has traded

ACURA PHARMACEUTICALS, INC89 tx · $1.2M · Nov 20, 2023

Track record of CLEMENS PETER A

Statistical track record

Free account

Open-market buys: 8

Last buy: Dec 14, 2017

Win rates, median returns and the proven-insider analysis come with a free account.

Create a free account

Transaction history of CLEMENS PETER A

Co-insiders of CLEMENS PETER A

Abuse Deterrent Pharma, LLCACURA PHARMACEUTICALS, INC
Azad DavidACURA PHARMACEUTICALS, INC
Boehm GarthACURA PHARMACEUTICALS, INC
Brzeczko Albert WACURA PHARMACEUTICALS, INC
CARE CAPITAL II LLCACURA PHARMACEUTICALS, INC
CARE CAPITAL INVESTMENTS II LPACURA PHARMACEUTICALS, INC
Care Capital Offshore Investments II LPACURA PHARMACEUTICALS, INC
CLAUDIUS LLCACURA PHARMACEUTICALS, INC
EMIGH JAMES FACURA PHARMACEUTICALS, INC
ESSEX WOODLANDS HEALTH VENTURES FUND V LLCACURA PHARMACEUTICALS, INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACURA PHARMACEUTICALS, INCListing on record	Nov 20, 2023	Exercise	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 20, 2023	ExerciseD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 5, 2023	Exercise	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 5, 2023	ExerciseD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	ExerciseD (derivative)	9,333	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	ExerciseD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	Exercise	49,333	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Mar 18, 2022	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	Exercise	40,000	0.15 USD	$6K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	Other	-15,100	0.40 USD	$6K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	ExerciseD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Other	-19,514	0.21 USD	$4.1K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	9,334	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Exercise	49,334	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	Exercise	9,334	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	Other	-3,090	0.23 USD	$710.7		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	ExerciseD (derivative)	9,334	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	120,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 15, 2017	Buy	300,000	0.10 USD	$30K	conv 95ClusterUnusual size+1	SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 11, 2017	AwardD (derivative)	28,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 10, 2017	AwardD (derivative)	34,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 12, 2016	AwardD (derivative)	34,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 14, 2015	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ACURA PHARMACEUTICALS, INCListing on record	Nov 20, 2023	Exercise	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Nov 20, 2023	ExerciseD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 5, 2023	Exercise	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 5, 2023	ExerciseD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	ExerciseD (derivative)	9,333	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	ExerciseD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 5, 2022	Exercise	49,333	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Mar 18, 2022	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	Exercise	40,000	0.15 USD	$6K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	Other	-15,100	0.40 USD	$6K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Feb 26, 2021	ExerciseD (derivative)	-40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Other	-19,514	0.21 USD	$4.1K		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	ExerciseD (derivative)	9,334	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2021	Exercise	49,334	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	Exercise	9,334	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	Other	-3,090	0.23 USD	$710.7		SEC
ACURA PHARMACEUTICALS, INCListing on record	Jan 6, 2020	ExerciseD (derivative)	9,334	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	120,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 17, 2018	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 15, 2017	Buy	300,000	0.10 USD	$30K	conv 95ClusterUnusual size+1	SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 11, 2017	AwardD (derivative)	28,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Aug 10, 2017	AwardD (derivative)	34,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 12, 2016	AwardD (derivative)	34,000	—	n/a (No price was disclosed in the filing)		SEC
ACURA PHARMACEUTICALS, INCListing on record	Dec 14, 2015	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC